The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C

BACKGROUND: A dinucleotide variant rs368234815 in interferon lambda 4 (IFNL4) gene was recently found to be associated with the hepatitis C virus (HCV) treatment response. This study aimed to assess the impact of IFNL4 rs368234815 polymorphism on treatment response to pegylated-IFN alpha (Peg-IFN-α)...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshvari, Maryam, Alavian, Seyed Moayed, Behnava, Bita, Pouryasin, Ali, Sharafi, Heidar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122234/
https://www.ncbi.nlm.nih.gov/pubmed/27904617
http://dx.doi.org/10.4103/1735-1995.189678

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122234/
https://www.ncbi.nlm.nih.gov/pubmed/27904617
http://dx.doi.org/10.4103/1735-1995.189678

Ejemplares similares